InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (18 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
18
T+90 hit rate
0%
T+90 mean return
-34.6%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Michaelson Jennifer, Executive. Director active across 2 companies, notably Cullinan Oncology, Inc.. Aggregated, 39 reports have been published. Split: 0 buy · 18 sells. Total volume traded: €696k. History available since 18 August 2021. The latest transaction was filed on 6 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations39 total
4,000 shares@ US$4.300.0018% mcap1.7% of flowCommon StockSEC:0001193125-26-297605:0
8,000 shares@ US$17.820.015% mcap13.9% of flowCommon StockSEC:0001193125-26-297605:1
3,756 shares@ US$8.534.0% of flowCommon StockSEC:0000950170-25-029200:0
50,000 shares0Common StockSEC:0000950170-25-025032:0
4,000 shares@ US$12.516.4% of flowCommon StockSEC:0000950170-25-002946:0
4,693 shares@ US$11.416.7% of flowCommon StockSEC:0000950170-24-139125:0
3,489 shares@ US$12.525.5% of flowCommon StockSEC:0000950170-24-136726:0
8,000 shares@ US$15.6415.2% of flowCommon StockSEC:0000950170-24-123538:0
8,000 shares@ US$18.0917.2% of flowCommon StockSEC:0000950170-24-104820:0
8,000 shares@ US$16.3316.0% of flowCommon StockSEC:0000950170-24-082485:0
2,360 shares@ US$9.002.6% of flowCommon StockSEC:0000950170-24-080961:0
50,000 shares@ US$4.3026.4% of flowCommon StockSEC:0000950170-24-056093:0
50,000 shares0Common StockSEC:0000950170-24-019456:0
1,145 shares@ US$8.503.1% of flowCommon StockSEC:0000950170-23-072753:0
238 shares@ US$8.220.6% of flowCommon StockSEC:0000950170-23-071988:0
1,068 shares@ US$7.812.7% of flowCommon StockSEC:0000950170-23-070142:0
238 shares@ US$12.941.0% of flowCommon StockSEC:0000950170-23-029160:0
176 shares@ US$13.110.7% of flowCommon StockSEC:0000950170-23-027984:0
11,900 shares@ US$4.3016.5% of flowCommon StockSEC:0000950170-23-027063:0
239 shares@ US$8.760.7% of flowCommon StockSEC:0000899243-23-013364:0
193 shares@ US$8.780.5% of flowCommon StockSEC:0000950170-23-022557:0
238 shares@ US$10.710.8% of flowCommon StockSEC:0000950170-23-013701:0
176 shares@ US$10.220.6% of flowCommon StockSEC:0000899243-23-011292:0
238 shares@ US$11.320.9% of flowCommon StockSEC:0000899243-23-009716:0
38,500 shares0Common StockSEC:0000899243-23-005729:0
25 of 39 declarations
About Michaelson Jennifer
Jennifer Michaelson is the Chief Development Officer at Cullinan Oncology, Inc. She is involved in business development strategy and innovation in the field of oncology.
